Targeted therapy in juvenile myelomonocytic leukemia: Where are we now?

导出原文传递

翻译打印收藏纠错

第一作者： Nele,De Vos

第一单位： Department of Pediatric Hematology-Oncology and Stem Cell Transplantation, Ghent University, Ghent, Belgium.

作者： Nele,De Vos ^[1] ; Mattias,Hofmans ^[2] ; Tim,Lammens ^[3] ; Bram,De Wilde ^[3] ; Nadine,Van Roy ^[4] ; Barbara,De Moerloose ^[5]

作者单位： Department of Pediatric Hematology-Oncology and Stem Cell Transplantation, Ghent University, Ghent, Belgium. ^[1] Department of Laboratory Medicine, Ghent University Hospital, Ghent, Belgium. ^[2] Cancer Research Institute Ghent, Ghent, Belgium. ^[3] Department of Pediatric Hematology-Oncology and Stem Cell Transplantation, Ghent University Hospital, Ghent, Belgium. ^[4] Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium. ^[5] Center for Medical Genetics Ghent, Ghent, Belgium. ^[6] Department of Biomolecular Medicine, Ghent University, Ghent, Belgium. ^[7]

关键词 JMML Ras pathway juvenile myelomonocytic leukemia targeted therapy

主题词儿童, 学龄前(Child, Preschool);造血干细胞移植(Hematopoietic Stem Cell Transplantation);人类(Humans);白血病, 粒-单核细胞, 幼年型(Leukemia, Myelomonocytic, Juvenile);突变(Mutation);骨髓增生异常综合征(Myelodysplastic Syndromes);原癌基因蛋白质类p21(ras)(Proto-Oncogene Proteins p21(ras))

DOI 10.1002/pbc.29930

PMID 36094370

发布时间 2022-11-08

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交